Psoriasis develops through interactions between the skin and immune system. The cell-signaling molecule Stat3 now emerges as a bridge between the two, initiating perturbations in the epidermis and generating misguided T-cell responses (pages 43–49).
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Nickoloff, B.J. & Nestle, F.O. J. Clin. Invest. 113, 1664–1675 (2004).
Wrone-Smith, T. & Nickoloff, B.J. J. Clin. Invest. 98, 1878–1887 (1996).
Boyman, O. et al. J. Exp. Med. 199, 731–736 (2004).
Gottlieb, A. & Bos, J. Clin. Immunol. 105, 105–116 (2002).
Sano, S. et al. Nat. Med. 10, 43–49 (2004).
Levy, D.E. & Darnell, J.E. Jr. Nat. Rev. Mol. Cell. Bio. 3, 651–662 (2002).
Chan, K.S. et al. Cancer Res. 64, 2382–2389 (2004).
Chan, K.S. et al. J. Clin. Invest. 114, 720–728 (2004).
Bromberg, J.F. et al. Cell 98, 295–303 (1999).
Bowcock, A.M. J. Invest. Dermatol. 122, xv–xvii (2004).
Cook, P.W. et al. J. Clin. Invest. 100, 2286–2294 (1997).
Cook, P.W. et al. Exp. Dematol. 13, 347–356 (2004).
Zhong, Z. et al. Science 264, 95–98 (1994).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pittelkow, M. Psoriasis: more than skin deep. Nat Med 11, 17–18 (2005). https://doi.org/10.1038/nm0105-17
Issue Date:
DOI: https://doi.org/10.1038/nm0105-17